Literature DB >> 2527315

NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: site of transcriptional initiation is independent of the TATA box.

A Bielinska1, S Krasnow, G J Nabel.   

Abstract

The activation of the human immunodeficiency virus (HIV) enhancer in T cells can occur through multiple independent pathways. This enhancer is stimulated by NF-kappa B or through alternative mechanisms, including E1A transactivation, which is dependent on the TATA box. In this report, the role of the TATA box in activation by NF-kappa B is examined. E1A stimulation of the HIV enhancer requires the presence of the TATA sequence in the sense orientation. Analysis of mutant HIV enhancer plasmids shows that basal mRNA levels are reduced when the TATA sequence is altered but that inducibility of NF-kappa B and the site of transcriptional initiation are unchanged. These data suggest that transcriptional initiation in this class II promoter is determined by an initiator factor which does not require binding to the TATA sequence. Because kappa B is found in a variety of viruses, this mechanism may be relevant to the activation of other viral enhancers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527315      PMCID: PMC251015     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay.

Authors:  B R Franza; S F Josephs; M Z Gilman; W Ryan; B Clarkson
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

2.  The "initiator" as a transcription control element.

Authors:  S T Smale; D Baltimore
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

3.  Definition of multiple, functionally distinct TATA elements, one of which is a target in the hsp70 promoter for E1A regulation.

Authors:  M C Simon; T M Fisch; B J Benecke; J R Nevins; N Heintz
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

4.  Promoters, activator proteins, and the mechanism of transcriptional initiation in yeast.

Authors:  K Struhl
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

5.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator.

Authors:  A Jakobovits; D H Smith; E B Jakobovits; D J Capon
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

7.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.

Authors:  G J Nabel; S A Rice; D M Knipe; D Baltimore
Journal:  Science       Date:  1988-03-11       Impact factor: 47.728

9.  The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

Authors:  E Böhnlein; J W Lowenthal; M Siekevitz; D W Ballard; B R Franza; W C Greene
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

10.  HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.

Authors:  K Leung; G J Nabel
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

View more
  22 in total

1.  Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter.

Authors:  M C Blake; R C Jambou; A G Swick; J W Kahn; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 2.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

3.  PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.

Authors:  W Yoo; M E Martin; W R Folk
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.

Authors:  M A Montano; K Kripke; C D Norina; P Achacoso; L A Herzenberg; A L Roy; G P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

6.  Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.

Authors:  S F Parker; L K Felzien; N D Perkins; M J Imperiale; G J Nabel
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID.

Authors:  S T Smale; M C Schmidt; A J Berk; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.

Authors:  L K Felzien; C Woffendin; M O Hottiger; R A Subbramanian; E A Cohen; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

9.  Transcription stimulation of the adenovirus type 12 E1a gene in vitro by the 266-amino-acid E1A protein.

Authors:  H Kawamura; N Wada; Y Makino; T A Tamura; S Koikeda; K Shiroki; Y Masamune; Y Nakanishi
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.

Authors:  L Duan; I Ozaki; J W Oakes; J P Taylor; K Khalili; R J Pomerantz
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.